Comparison of the Velogene Rapid MRSA Identification Assay, Denka MRSA-Screen Assay, and BBL Crystal MRSA ID system for rapid identification of methicillin-resistant Staphylococcus aureus

被引:18
作者
Arbique, J [1 ]
Forward, K [1 ]
Haldane, D [1 ]
Davidson, R [1 ]
机构
[1] Queen Elizabeth II Hlth Sci Ctr, Div Microbiol, Halifax, NS B3H 1V8, Canada
关键词
D O I
10.1016/S0732-8893(01)00245-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Early detection of methicillin-resistant S. aureus (MRSA) is critical for both the management of infected patients, and the timely institution of appropriate infection control measures. Although detection of the mecA gene by PCR remains the gold standard, this technology is inaccessible for many laboratories. Therefore, we sought to evaluate several new rapid identification systems and compare them to PCR. A total of 71 methicillin-susceptible S. aureus (MSSA), 25 borderline oxacillin-resistant S. aureus (BORSA), and 213 MRSA were selected for study. S. aureus was identified using standard methods. Initial screening was performed on a Mueller-Hinton agar plate with 6 mg/L of oxacillin. MRSA strains were identified using PCR with primers specific for the mecA gene. PCR was used as the reference method. All isolates were tested using the BBL Crystal MRSA LD System (Becton Dickinson Microbiology Systems, Maryland, USA), the MRSA-Screen Assay (Denka Seiken Co., Ltd., Tokyo, Japan), and the Velogene Rapid MRSA Identification Assay (ID Biomedical Corp, Vancouver, BC). With minor modifications, all assays were performed according to manufacturers' instructions. Overall, the 3 commercial assays performed well. The sensitivity and specificity of the BBL, Denka, and Velogene systems were 99%/100%, 99%/100%, and 96%/100% respectively. The advantages of the phenotypic tests-BBL Crystal Kit and Denka MRSA-Screen Assay include lower cost per test, shelf-life, ease of use, and rapid turn-around times. Advantages of the Velogene Rapid MRSA include ability to perform genotypic high-volume testing without the equipment requirements and technical complexity involved with PCR. Turn-around times ranged from 15 min for the Denka MRSA-Screen Assay, 2 h for the Velogene Rapid MRSA, and 4 h for the BBL Crystal. The BBL Crystal, Denka MRSA-Screen, and Velogene Rapid MRSA identification systems are rapid, easy to perform, and provide accurate identification of MRSA. These rapid kits offer an acceptable alternative for smaller, non-reference, laboratories and reduce the dependency on PCR in larger laboratories for routine confirmation. (C) 2001 Elsevier Science Inc. All rights reserved.
引用
收藏
页码:5 / 10
页数:6
相关论文
共 16 条
  • [1] Detection of the mec-A gene and phenotypic detection of resistance in Staphylococcus aureus isolates with borderline or low-level methicillin resistance
    Bignardi, GE
    Woodford, N
    Chapman, A
    Johnson, AP
    Speller, DCE
    [J]. JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1996, 37 (01) : 53 - 63
  • [2] Evaluation of MRSA-screen, a simple anti-PBP 2a slide latex agglutination kit, for rapid detection of methicillin resistance in Staphylococcus aureus
    Cavassini, M
    Wenger, A
    Jaton, K
    Blanc, DS
    Bille, J
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (05) : 1591 - 1594
  • [3] HALL GS, 2000, ASM GEN M LOS ANG CA
  • [4] *ID BIOM CORP, 1999, VEL RAP MRSA ID ASS
  • [5] Evaluation of the BBL Crystal MRSA ID System for detection of oxacillin resistance in Staphylococcus aureus
    Kampf, G
    Lecke, C
    Cimbal, AK
    Weist, K
    Rüden, H
    [J]. JOURNAL OF CLINICAL PATHOLOGY, 1999, 52 (03) : 225 - 227
  • [6] KLOOS WE, 1999, MANUAL CLIN MICROBIO, P271
  • [7] EVALUATION OF BBL CRYSTAL MRSA ID SYSTEM
    KNAPP, CC
    LUDWIG, MD
    WASHINGTON, JA
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1994, 32 (10) : 2588 - 2589
  • [8] Oxacillin susceptibility testing of staphylococci directly from bactec plus blood cultures by the BBL crystal MRSA ID system
    Kubina, M
    Jaulhac, B
    Delabranche, X
    Lindenmann, C
    Piemont, Y
    Monteil, H
    [J]. JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (06) : 2034 - 2036
  • [9] LINSCOTT JJ, 2000, ASM GEN M LOS ANG CA
  • [10] Louie L, 2000, J CLIN MICROBIOL, V38, P2170